Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 2, 2004British Journal of Haematology

Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature

View Full Paper
Ask AI
Bookmark
Share

Authors

RYRoslyn YomtovíanLouis Stokes Cleveland VA Medical CenterWNWaldemar NiklinskiJohn H. Stroger, Jr. Hospital of Cook CountyBSBernard SilverCleveland Clinic

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yomtovían et al. (2004) studied this question.

synapsesocial.com/papers/6a96e2c10f79e4f014b31146https://doi.org/10.1111/j.1365-2141.2004.04836.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura2001 · 551 citations
  2. 2Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy2001 · 359 citations
  3. 3Late Relapses in Patients Successfully Treated for Thrombotic Thrombocytopenic Purpura1995 · 176 citations